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The role of TNF-α in chlamydial clearance is uncertain. Antibody-mediated depletion of
TNF-α in mice and guinea pigs has been shown not to significantly affect chlamydial
clearance, whereas production of TNF-α in addition to IFN-γ from T cells has been shown
to correlate with enhanced clearance. The aim of our study is to evaluate the mechanistic
role of TNF-α in clearance of primary and secondary chlamydial infection from the genital
tract (GT) using C57BL/6 TNF-α deficient (TNF-α−/−) and wild type (WT) mice. Chlamydial
shedding from the lower GT was evaluated following primary and secondary intravaginal
challenge. Also, antibody and antigen specific cytokine responses were analyzed from the
infected GT and spleens, and oviduct pathology determined to analyze the role of TNF-α
in upper GT pathological sequelae. MHC II−/− mice, known to display muted adaptive
immune responses and failure to resolve genital chlamydial infections, were used as
a negative control. Following both primary and secondary genital chlamydial infection,
TNF-α−/− mice exhibited elevated granzyme B production, but similar IFN-γ and antibody
responses. Importantly, absence of TNF-α did not significantly alter the resolution of
infection. However, TNF-α−/− mice displayed significantly reduced upper genital tract
(UGT) pathology compared to WT mice. This study demonstrates mechanistically that
optimal chlamydial clearance following primary and secondary chlamydial genital infection
can occur in the complete absence of TNF-α, and considered with the reduction of
upper GT pathology in TNF-α−/− mice, suggests that targeted induction of anti-chlamydial
TNF-α responses by vaccination may be unnecessary, and moreover could be potentially
pathogenic.
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INTRODUCTION
Chlamydia trachomatis, a Gram-negative obligate intracellular
bacterium, is the leading cause of bacterial sexually transmitted
diseases (STDs) worldwide. In females, the majority of cases are
initially asymptomatic and, when left untreated, may ascend to
the upper genital tract (UGT) and cause severe sequelae includ-
ing pelvic inflammatory disease, ectopic pregnancy, and infertility
(Morrison and Caldwell, 2002; Debattista et al., 2003; Brunham
and Rey-Ladino, 2005; Meldrum et al., 2007). Although there
is efficacious antimicrobial therapy (Beale et al., 1991; Beale
and Upshon, 1994; Su et al., 1999), a continual increase in the
incidence of chlamydial STD argues for the development of a
safe preventive vaccine (Morrison and Caldwell, 2002; Debattista
et al., 2003; Brunham and Rey-Ladino, 2005).
Infection with Chlamydia in the genital tract (GT) induces
the production of several pro-inflammatory cytokines such as
TNF-α, IL-1, and IL-6, chemokines such as IL-8, and inflamma-
tory cytokines including IL-12, IFN-γ, and IL-17 (Su et al., 1999;
Brunham and Rey-Ladino, 2005; Murthy et al., 2011). Among
these, IL-12 and IFN-γ have been shown previously to con-
tribute to protective immunity against chlamydial GT infection
(Brunham and Rey-Ladino, 2005). The role of TNF-α in chlamy-
dial infections has been studied previously. Transcripts of TNF-α
are found in the infected GT tissues as early as day 3 after infec-
tion (Morrison and Morrison, 2000). We and others also have
shown that there is an initial surge of TNF-α production in the
GTs of infected mice during the first week of infection, and that
the levels gradually reduce during the subsequent weeks of infec-
tion (Darville et al., 1995, 1997; Murthy et al., 2011). TNF-α has
pleiotropic effects: it is a potent chemoattractant of neutrophils
and acts as a key transcription factor in the NF-kappa B andMAP
kinase pathways triggering inflammation, immune cell prolifer-
ation and apoptosis (Strieter et al., 1989; Wajant et al., 2003).
Specifically, it is known that apoptosis and fibrosis are due to the
effects of TNF-α via caspase-8 activation (Alikhani et al., 2004),
and that soluble TNF mediates fibrosis in the lung (Oikonomou
et al., 2006). Importantly, we have shown recently that TNF-α
production contributes to upper GT pathology following vaginal
chlamydial infection in mice (Murthy et al., 2011). In that study,
we also showed that TNF-α was not required for clearance of
primary genital chlamydial infections. However, a detailed eval-
uation of compensatory immunological parameters or the role of
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TNF-α production in clearance of secondary genital chlamydial
infections was not conducted in that study.
One of the well-recognized roles of TNF-α is in killing of intra-
cellular microbes. There is evidence showing that the addition of
recombinant TNF-α in vitro inhibits intracellular replication of
C. trachomatis in human laryngeal carcinoma cells (Hep-2 cells)
(Manor and Sarov, 1988). However, the effects of TNF-α in the
clearance of in vivo chlamydial infections are uncertain. Darville
et al. (2000), demonstrated that TNF-α depleted mice and guinea
pigs, when infected with Chlamydia, show comparable clearance
and levels of infection to their respective WT animal controls.
However, the investigators suggested that the anti-TNF-α anti-
body used to deplete the cytokine might not have been sufficient
for complete depletion. In contrast, Caldwell et al. suggested that
TNF-α may be important for chlamydial resistance in vivo since
TNF-α p55 receptor gene deficient mice displayed significantly
enhanced chlamydial shedding, but comparable time to clear-
ance of Chlamydia muridarum (C. muridarum), when compared
to corresponding WT mice (Perry et al., 1999b). More recently,
reduced chlamydial shedding from the GT on day 10 after chal-
lenge in vaccinated mice was found to correlate better with
frequencies of T cells producing both TNF-α and IFN-γ, than
those producing IFN-γ alone, thus suggesting that TNF-α may
be one of the effector cytokines contributing to optimal protec-
tion in Chlamydia vaccinated mice (Yu et al., 2011). Collectively,
these disparate observations emphasize the need for a detailed
evaluation of the role of TNF-α in clearance of genital chlamydial
infections.
In this study, we evaluated the host responses to C. muri-
darum in the absence of TNF-α following both primary and
secondary intravaginal infection, using TNF-α−/− and the cor-
responding WT C57BL/6 mice. We hypothesized that TNF-α
would contribute to chlamydial clearance and thus TNF-α−/−
mice would display significantly reduced chlamydial clearance
compared to WT mice. A known mouse model of MHC II
gene deficiency (MHC II−/− mice), which has been determined
previously to be significantly deficient in chlamydial clearance
(Murthy et al., 2006), was used as a negative control for all exper-
iments. We found that the mice deficient in TNF-α did not show
significant differences in resolution of either primary or sec-
ondary C. muridarum infection. Additionally, the cell mediated
and humoral responses were generally comparable in TNF-α−/−
and WT C57BL/6 mice. In contrast, oviduct pathology in TNF-
α−/− mice was significantly less than in WT animals, suggesting
that TNF-α may play a role in triggering inflammatory responses
leading to the oviduct pathology.
MATERIALS AND METHODS
Chlamydia muridarum AND MICE
Chlamydia muridarum Nigg (C. muridarum) strain was grown
in HeLa 229 cells, and elementary bodies (EBs) were obtained
using a Renografin gradient separation method as described pre-
viously (Wang et al., 2009; Nagarajan et al., 2011). UV inactivated
organisms were generated by subjecting purified EBs to 45min
of UV irradiation using an UV crosslinker. Female, 4–6 week
old C57BL/6 WT mice and breeding pairs of TNF-α deficient
(TNF-α−/−) and MHC class II deficient (MHC II−/−) mice were
purchased from the Jackson Laboratory and maintained at the
University of Texas at San Antonio and Midwestern University.
Food and water were supplied ad libitum and all experimental
procedures followed the guidelines of the Institutional Animal
Care and Use Committee (IACUC) at both institutions.
INTRAVAGINAL INFECTION OF MICE AND MONITORING OF BACTERIAL
SHEDDING
WT, TNF-α−/− and MHC class II−/− mice received 2.5mg per
mouse of Depoprovera (medroxy-progesterone acetate) subcu-
taneously at 10 and 3 days before vaginal challenge in order
to render the mice anestrous and more receptive to the genital
infection. The mice were then challenged with 5 × 104 inclusion-
forming units (IFU) of C. muridarum contained in 10μl of
sucrose-phosphate-glutamate buffer placed into the cervico-
vaginal vault. The course of infection was followed by swabbing
the cervico-vaginal vault every 3 days following inoculation. For
secondary challenge, animals that recovered from primary infec-
tion were administered 0.03mg Doxycycline intraperitoneally
(i.p) in 100μl phosphate-buffered saline (PBS) (Jupelli et al.,
2011) each day on days 60–63 following primary challenge to
ensure clearance of the primary infection. Mice were rested for 1
week and rechallenged with 5 × 104 EBs following Depoprovera
treatment, as described above. To assess bacterial burdens, swabs
were collected in Eppendorf tubes containing 4mm glass beads
(Kimble, Vineland,NJ) and 500μl of sterile SPG buffer. The tubes
were vortexed for 1min, and swab material was plated onto HeLa
cells grown on coverslips in 24-well plates and incubated for 30 h.
The infected HeLa cells were fixed with 2% paraformaldehyde
and permeabilized with 2% saponin. Cells were washed using PBS
and incubated for 1 h with Dulbecco’s modified Eagle’s medium
containing 10% fetal bovine serum to block non-specific bind-
ing. Thereafter, cells were washed and incubated with polyclonal
rabbit anti-Chlamydia antibody for 1 h and then incubated for an
additional 2 h with goat anti-rabbit immunoglobulin conjugated
to fluorescein isothiocyanate (Sigma, St. Louis, MO) along with
Hoechst nuclear stain. The treated coverslip cultures were then
washed and mounted on Superfrost microscope slides (Fisher)
using Fluorsave reagent (Calbiochem, La Jolla, CA), and the
chlamydial IFUs were visualized using a Zeiss Axioskop 2 Plus
research microscope (Zeiss, Thornwood, NY).
EVALUATION OF CYTOKINE AND ANTIBODY RESPONSES
Eight days after challenge with C. muridarum, mice (3 per group)
were euthanized andGTs collected and homogenized individually
in PBS containing protease inhibitor. Supernatants were collected
after centrifugation at 5000 rpm for 10min and analyzed. In some
experiments, 14 days after primary infection with C. muridarum,
mice (3 per group) were euthanized, spleens collected, and single
cell suspensions made. Splenocytes (106 cells/well) were stimu-
lated with 104 UV irradiated EB, or the unrelated protein hen
egg lysozyme (HEL), or medium alone, and incubated for 72 h. In
experiments where splenocytes were collected at 12 days after sec-
ondary challenge, it was assumed that the cells would have been
restimulated in vivo, and therefore additional in vitro antigenic
stimulation was not provided. Supernatants were collected and
assayed for IFN-γ using BD OptEIA™ kits (BD Pharmingen, San
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Diego, CA); and for TNF-α and granzyme B using Ebioscience
kits (San Diego, CA). The levels of respective cytokines were
quantified by measuring the absorbance at 630 nm using a
μQuant ELISA plate reader (BioTek Instruments, Winooski, VT).
Antibody ELISA tests were conducted on sera collected at 40
days after primary infection with live EB and at 12 days after
reinfection with live EB. Microtiter plates were coated with 105
UV-EB, or the unrelated antigen HEL, and incubated overnight
at 4◦C. Serial dilutions of sera were performed in the plates fol-
lowed by incubation for 2 h. After 3 washes, goat anti-mouse
total Ig (H+L), IgG2a, IgG2b, or IgG2c conjugated to horseradish
peroxidase (HRP) was added as secondary antibody (Southern
Biotechnology). Tetramethylbenzidine was used as substrate and
the resulting absorbance quantified at 630 nm using a μQuant
ELISA plate reader (BioTek Instruments, Winooski, VT).
ESTIMATION OF UTERINE HORN AND OVIDUCT PATHOLOGY
UGT pathology was evaluated on day 70 post-challenge. Mice
(6 per group) were euthanized, GTs removed and examined for
the presence of gross hydrosalpinx. The tissues were then aligned
next to a standard metric ruler and photographed from a fixed
distance using a 6 mega-pixel Fuji F10 camera. Images were
stored at high resolution and printed on sheets (A4 size) of paper.
Dilated oviducts measuring >0.5mm in diameter were used as
an indicator of hydrosalpinx. When multiple oviduct loops were
present, the one with the greatest diameter was reported. For
uterine horns, the average of the greatest cross-sectional diame-
ter of each 5-mm longitudinal section was reported. The baseline
normal mouse oviduct diameter was determined to be 0.5mm
and normal uterine horn diameter to be 1mm by prior analy-
sis of a group of age-matched naïve mice. Pooled data from two
experiments was analyzed for statistically significant differences.
STATISTICAL ANALYSES
Sigma Stat (Systat Software Inc., San Jose, CA) was used to per-
form all tests of significance. Analysis of variance (ANOVA; Systat,
CA) was used for all comparisons. Differences between groups
were considered statistically significant if P-values were ≤0.05.
All experiments were repeated at least twice, and each experi-
ment was analyzed independently. In experiments where oviduct
and uterine horn diameter data are shown as a composite of two
experiments, the indicated significant difference holds true when
the experiments are analyzed individually.
RESULTS
EFFECT OF TNF-α ON CLEARANCE OF Chlamydia muridarum PRIMARY
GENITAL INFECTION
Groups (n = 6) of WT, TNF-α−/−, and MHC II−/− mice were
challenged with 5 × 104 IFUs of C. muridarum and chlamydial
numbers in vaginal swabs were monitored every 3 days for 30
days. WT mice shed high numbers of bacteria at early time-
periods and displayed a progressive reduction in vaginal chlamy-
dial shedding with complete clearance by day 30 after primary
infection (Figure 1). The kinetics of resolution of infection in
TNF-α−/− mice was comparable to that inWTmice. As expected,
MHC II−/− mice continued to display a high level of chlamydial
shedding throughout the period of monitoring and none of the
FIGURE 1 | Chlamydial clearance following primary genital infection
with C. muridarum. Groups of C57BL/6 WT, TNF-α−/−, and MHC II−/−
mice (n = 6) were swabbed and analyzed every 3 days over a 30 day period
for numbers of chlamydial IFU recovered following primary genital infection
with C. muridarum. Results are represented as mean±SEM of chlamydial
recovery per mouse group at each time point. ∗Significant (p ≤ 0.05,
Two-Way ANOVA) differences between MHC II−/− and WT or between
MHC II−/− and TNF-α−/− mice at the indicated time-periods. Results are
representative of two independent experiments.
mice in this group had cleared the infection at day 30 after pri-
mary infection. At day 12, and every time-point thereafter, WT
and TNF-α−/− mice displayed a significant reduction in vagi-
nal chlamydial shedding when compared to MHC II−/− mice.
These results suggest that the presence of TNF-α is not required,
nor does it significantly affect the clearance of primary genital
infection with C. muridarum.
EFFECT OF TNF-α ON IMMUNE RESPONSES TO Chlamydia muridarum
PRIMARY GENITAL INFECTION
We have found previously that the granzyme and perforin path-
way contributes to the GT pathology following chlamydial infec-
tion (Murthy et al., 2011). To evaluate any compensatory effects
of granzyme inmice lacking TNF-α production, we also evaluated
the production of granzyme in these assays. We have observed
previously that the levels of TNF-α and granzyme B peaked at
approximately 1 week following primary genital chlamydial chal-
lenge in theWTmouse GT, but returned to normal levels as weeks
progressed (Murthy et al., 2011). Therefore, GTs from infected
WT, TNF-α−/− and MHC II−/− mice were removed on day 8
post challenge and analyzed for IFN-γ, TNF-α and granzyme
B production (Figure 2). TNF-α production by WT mice was
greater, albeit not significantly, than that exhibited by MHC
II−/−and as expected not detectable in TNF-α−/− mice.WTmice
displayed the highest levels of IFN-γ production, followed by
TNF-α−/− and MHC II−/− mice, respectively, although no sig-
nificant differences were observed. On the other hand, granzyme
B levels were comparable between WT and MHC II−/− mice,
and both were significantly lower compared to that in TNF-α−/−
animals.
In order to measure Ag-specific cellular cytokine production,
spleens were collected from WT, TNF-α−/−, and MHC II−/−
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FIGURE 2 | Cytokine production in genital tracts following primary
genital infection with C. muridarum. Genital tracts of individual mice
from each group (n = 3) on day 8 after primary genital challenge with C.
muridarum were harvested, homogenized, and TNF-α, IFN-γ, and granzyme
B measured. Results are represented as mean±SEM for each cytokine per
mouse group. ∗Significant (p ≤ 0.05, ANOVA) difference between the
indicated groups. Results are representative of two independent
experiments.
mice on day 14 following primary genital challenge with
C. muridarum, single cells prepared and stimulated with UV
inactivated EBs and supernatants analyzed for the same three
cytokines. As shown in Figure 3, WT mice displayed significantly
higher levels of TNF-α production when compared to MHC
II−/− mice, and both these groups produced significantly greater
TNF-α than TNF-α−/− mice, which as expected did not display
TNF-α production. High, and comparable, levels of Ag-specific
IFN-γ production were observed in WT and TNF-α−/− mice,
and both displayed significantly higher levels than MHC II−/−
animals. Granzyme B production in WT mice was significantly
higher than inMHC II−/− mice, and the levels in TNF-α−/− mice
were significantly greater than that in either WT or MHC II−/−
mice. In all groups of mice, splenocytes stimulated with the unre-
lated antigen HEL and media alone produced low minimal levels
of TNF-α, IFN-γ, and granzyme B (data not shown).
Mice bled at day 40 after primary challenge were mea-
sured for antibody levels (Figure 3). Robust and comparable
serum antibody responses for total IgG (Figure 3) and IgG1,
IgG2b, and IgG2c isotypes (data not shown) were observed
in WT and TNF-α−/− mice, and both displayed significantly
higher titers of all the measured antibody isotypes when com-
pared to MHC II−/− mice which, as expected, displayed min-
imal antibody responses. Serum antibody responses against the
unrelated antigen HEL was undetectable (data not shown).
Together, these results clearly indicate that the absence of
TNF-α during the chlamydial infection process does not sig-
nificantly affect IFN-γ production in the infected GT, or
Chlamydia-specific IFN-γ and antibody production. However,
granzyme B production in the infected GT and from Ag-specific
splenocytes increased significantly in mice deficient in TNF-α
production.
FIGURE 3 | Antigen specific cytokine responses measured from
splenocytes and serum antibody response after primary genital
infection with C. muridarum. Spleens from different groups of mice
were collected at 14 days after primary genital challenge with
C. muridarum and levels of IFN-γ, TNF-α and granzyme B produced by
splenocytes were measured from supernatants 72h after in vitro
stimulation of the splenocytes with UV-inactivated EBs, unrelated
antigen, or medium alone. Results are represented as mean±SEM for
each cytokine per mouse group. ∗Significant (p ≤ 0.05, ANOVA)
difference between the indicated groups. Results are representative of
two independent experiments. Total Ig from the different groups of
mice were measured against UV inactivated EBs in serum collected
from infected animals on day 40 after primary genital challenge with C.
muridarum. Results are represented as mean±SEM of reciprocal titers
corresponding to 50% maximum binding. ∗Significant (p ≤ 0.05, ANOVA)
difference between the indicated groups. Results are representative of
two independent experiments.
EVALUATION OF THE EFFECT OF TNF-α ON UPPER GENITAL TRACT
PATHOLOGICAL SEQUELAE FOLLOWING Chlamydia muridarum
PRIMARY GENITAL INFECTION
The development of oviduct and uterine horn dilatation are char-
acteristic sequelae to genital chlamydial infection in WT mice.
At day 80 after bacterial challenge, mice were euthanized and
GTs were collected for evaluating pathology. GTs were pho-
tographed and pathology was scored by measuring the cross
sectional diameter of the tissue (Murthy et al., 2011). The inci-
dence of oviduct dilatation in WT (18/24) and MHC II−/−
(17/24) mice was significantly higher than in TNF-α−/− (11/24)
mice (Figure 4). Additionally, the degree of dilatation in the
affected oviducts was significantly greater inWT, when compared
to TNF-α−/− mice, with an intermediate level of dilatation in
MHC II−/− mice which was not significantly different from the
other groups. The incidence of uterine horn dilatation in WT
(23/24) and MHC II−/− (20/24) mice was significantly higher
than in TNF-α−/− (11/24) mice. Additionally, the degree of
dilatation in the affected uterine horns was significantly reduced
in TNF-α−/− mice when compared to either WT or MHC II−/−
mice. The level of uterine horn dilatation in MHC II−/− mice
was reduced, albeit not significantly, when compared toWTmice.
Collectively, these results suggest that TNF-α produced from
Chlamydia infected cells contributes significantly to development
of UGT pathologies.
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FIGURE 4 | Upper genital tract pathological sequelae following
primary genital infection with C. muridarum. Genital tract tissues from
animals were harvested at 80 days after primary genital challenge with C.
muridarum and pathology was evaluated by measuring the cross sectional
diameter of both the oviduct and uterine horn as an inductor of the severity
of inflammation. Results are represented as individual oviduct or uterine
horn cross-sectional diameter and the mean±SEM for each mouse group
also is shown. A horizontal line at 0.5mm for oviduct diameter and 1mm
for uterine horn diameter represents the distinction between normal and
dilated. The ratio of the number of oviducts or uterine horns that were
normal to the total number examined are indicated above the X-axis for
each mouse group. ∗Significant (p ≤ 0.05, ANOVA) difference between the
indicated groups, as analyzed from pooled data. Results are representative
of two independent experiments.
EFFECT OF TNF-α ON SECONDARY GENITAL INFECTIONWITH
Chlamydia muridarum
Animals were treated with doxycycline for 4 days starting at 60
days after primary challenge and were swabbed to ensure that
the infection was cleared in all groups of mice, especially the
MHC II−/− mice (data not shown). The mice were rested for a
week before they were reinfected intravaginally with 5 × 104 IFU
of C. muridarum. As shown in Figure 5, all of the reinfected
mice displayed high levels of chlamydial shedding at day 3 after
secondary infection. WT and TNF-α−/− mice rapidly cleared
C. muridarum by day 6, whereas MHC II−/− mice continued to
shed high numbers (>104 IFU) of the organism even on day 9 fol-
lowing reinfection, displaying similar kinetics as in the primary
infection. At day 12 after secondary challenge, splenocytes were
cultured in vitro for 72 h and the supernatants were analyzed for
TNF-α, IFN-γ, and granzyme B. As shown in Figure 6, the anti-
gen specific TNF-α and IFN-γ responses followed a similar trend
as in primary infection, but, as expected, much higher levels of
cytokines were produced. Granzyme B production between the
groups also followed a similar trend, but at notably reduced levels,
to that seen in primary infection. Additionally, robust serum anti-
body responses, including total IgG (Figure 6), IgG1, IgG2b, and
IgG2c, (data not shown) against C. muridarum were observed in
reinfected WT and TNF-α−/− mice with reduced levels in MHC
II−/− mice. As seen with the Ag-specific cytokine responses,
antibody responses following secondary infection between the
different groups of mice followed a similar trend, albeit at much
higher levels, to that observed following primary infection, with
no significant reduction in the absence of TNF-α.
FIGURE 5 | Chlamydial clearance following secondary genital infection
with C. muridarum. Sixty days following primary genital infection with C.
muridarum, mice from each animal group (n = 6) were treated for 4 days
with Doxycycline (30μg/mouse/day) to ensure that the animals cleared
Chlamydia. After the Doxycycline treatment, mice were swabbed every
third day for 9 days to document chlamydial clearance. All mice were then
given Depo-progesterone (day 70), and 5 days later re-challenged
intravaginally with 5 × 104 EBs. Mice were swabbed and analyzed for
chlamydial IFU recovered every third day for 9 days. Results are represented
as mean±SEM of chlamydial recovery per mouse group at each time point.
∗Significant (p ≤ 0.05, One-Way ANOVA) differences between MHC II−/−
and WT or between MHC II−/− and TNF-α−/− mice at the indicated time
periods. Results are representative of two independent experiments.
DISCUSSION
The role of TNF-α in the mouse model of genital chlamydial
infection has not been fully resolved. Previous studies using anti-
TNF-α antibody or TNF-α R1 gene deficient mice displayed
a minimal role for TNF-α in clearance of primary genital
C. muridarum infection (Perry et al., 1999b). However, there
has been renewed interest in the contribution of this cytokine
to protective immunity based on a recent report of correlation
between T cells producing TNF-α in addition to IFN-γ and
chlamydial clearance (Yu et al., 2011). In our study, we used
gene knockout mice incapable of TNF-α production, and found
that clearance of both primary and secondary infection was not
significantly affected in the complete absence of TNF-α produc-
tion. However, TNF-α deficient mice did display minimal UGT
pathology, further confirming our recent demonstration of this
phenomenon and suggesting that TNF-α contributes to UGT
pathology (Murthy et al., 2011).
We and others have shown previously that TNF-α produc-
tion within the GT is seen in the first few weeks following
Chlamydia challenge (Darville et al., 2000; Murthy et al., 2011).
Given the known pleiotropic effects of TNF-α in inducing inflam-
mation, bacterial clearance, apoptosis, and pro-survival signals
(Strieter et al., 1989; Wajant et al., 2003; Alikhani et al., 2004;
Oikonomou et al., 2006), it would be reasonable to expect that
this cytokine would contribute during genital chlamydial infec-
tion. TNF-α has been shown to exert these effects mainly via
two receptors: TNF receptor 1 (TNFR1) and TNFR2 (Wajant
et al., 2003). The results from the current study suggest that
gene deficiency leading to lack of TNF-α production does not
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FIGURE 6 | Antigen specific cytokine responses measured from
splenocytes and serum antibody response after secondary genital
infection with C. muridarum. Spleens from different groups of mice were
collected at 12 days after secondary genital challenge with C. muridarum,
single cells prepared, and levels of IFN-γ, TNF-α and granzyme B produced
by the splenocytes were measured from supernatants 72 h after incubation
in media alone. These cells were considered to be re-stimulated with
antigen in vivo. ∗Significant (p ≤ 0.05, ANOVA) difference between the
indicated groups. Results are representative of two independent
experiments. Total Ig from the different groups of mice were measured
against UV inactivated EBs in serum collected from infected animals on day
12 following secondary genital challenge with C. muridarum. Results are
represented as mean±SEM of reciprocal titers corresponding to 50%
maximum binding. ∗Significant (p ≤ 0.05, ANOVA) difference between the
indicated groups. Results are representative of two independent
experiments.
significantly affect the clearance of either primary or secondary
genital chlamydial infection. This is in agreement with results
from the study using anti-TNF-α antibody to deplete the cytokine
(Darville et al., 2000). However, a contribution of signaling via
TNFR1 to controlling chlamydial burden, without affecting time
to resolution, during primary infection in the mouse GT has been
documented (Perry et al., 1999b). First, the insignificant differ-
ence in chlamydial burdens between WT and TNF-α deficient
mice was not due to our inability to detect such a difference
since we could clearly show the elevated chlamydial burden in
MHC II deficient mice. While we are unclear about the precise
reason for this subtle discrepancy, we can suggest some pos-
sibilities. First, TNF-α signals via multiple receptors, and the
effect of individual receptor signaling pathways may comple-
ment or oppose each other; therefore, an isolated deficiency of
TNFR1 may not be the same as complete absence of TNF-α.
A study comparing the individual effects of the TNF receptors
may address this issue. Second, the Perry et al. study showed that
TNF-α did not have any measurable effect on in vitro growth
of C. muridarum, suggesting that any effect of this cytokine on
chlamydial growth may be mediated indirectly by activating other
cell types and cytokine production (Perry et al., 1999b). Since
gene deficient mice have been known to display bystander effects
on non-targeted molecules, it may be that components of the
immune system other than TNF-α or TNFR1 were affected differ-
ently in these models and thereby had an impact on chlamydial
burdens. For example, the levels of granzyme were significantly
higher during the chlamydial infection in TNF-α deficient mice
when compared to WT animals. Previous studies from our
group (Murthy et al., 2011) and others (Perry et al., 1999a)
have shown that perforin does not contribute significantly to
chlamydial clearance. However, the levels of IFN-γ and antibody
production, which have been shown to contribute to chlamydial
clearance (Brunham and Rey-Ladino, 2005), were comparable
between TNF-α deficient and WT animals. A similar assess-
ment of the profiles of different components of the immune
system was not conducted in the Perry et al. study (Perry et al.,
1999b), making it difficult to obtain further insights into such
differences.
TNF-α deficient mice displayed significantly reduced oviduct
pathology when compared to WT animals following primary
genitalC. muridarum infection. This confirms our recent demon-
stration of the role of TNF-α in chlamydial pathogenesis in
the mouse model, and is supported by evidence of a role of
TNF-α in chlamydial pathologies in Chlamydia-induced infertil-
ity in humans (Ohman et al., 2009). Furthermore, we (Murthy
et al., 2011) and others (Perry et al., 1999a) have shown previ-
ously that perforin deficient mice display significantly reduced
pathology compared to wild type (WT) animals, suggesting a
role for granzymeB/perforin pathway in chlamydial pathogen-
esis. In this study, TNF-α deficient mice displayed significantly
reduced UGT pathology, but high levels of granzyme B produc-
tion in infected GTs and from antigen-specific splenocytes. This
suggests that the increased granzyme B production may repre-
sent a compensatory mechanism for the deficiency of TNF-α.
Conversely, TNF-α may directly or indirectly negatively regu-
late the production of granzyme B in WT animals. Further
studies will be needed to obtain detailed insights into the con-
tribution of granzyme B in this model. The identification of a
pathogenic role for TNF-α has several implications. First, TNF-α
may serve as a molecular target to reduce the clinically relevant
reproductive pathologies that follow genital chlamydial infec-
tions. Anti-TNF-α therapies are used in clinics currently for
inflammatory bowel disease and arthritis (Huang et al., 2012;
Perrier and Rutgeerts, 2012), and serve as an attractive future
solution to reduce reproductive pathologies induced by geni-
tal chlamydial infection. Second, since TNF-α is induced early
during the infection, this may serve as an early biomarker of dis-
ease development. A subset of individuals who contract genital
chlamydial infections develop reproductive tract sequelae, but at
present, no biomarkers have been identified to accurately predict
impending disease in infected individuals. Third, this has impli-
cations to ongoing vaccine development efforts. The correlation
between frequencies of IFN-γ and TNF-α producing CD4+ T
cells and chlamydial clearance has recently been suggested as a
justification to target the induction of Chlamydia-specific TNF-
α, along with IFN-γ, for an efficacious anti-chlamydial vaccine
(Yu et al., 2011). While a contribution of TNF-α to chlamy-
dial clearance cannot be fully excluded, the finding from our
study that kinetics of resolution of primary and secondary gen-
ital chlamydial infection was indistinguishable from WT, even
in the total absence of TNF-α production, suggests that induc-
tion of a TNF-α response is not a necessity for anti-chlamydial
Frontiers in Cellular and Infection Microbiology www.frontiersin.org March 2013 | Volume 3 | Article 11 | 6
Kamalakaran et al. Chlamydial clearance independent of TNF-α
protective immunity. Furthermore, the evidence of a role for
TNF-α in chlamydial pathogenesis is compelling. Collectively,
the contributions of TNF-α in genital chlamydial infections in
context of both protective immunity and pathogenesis should
be considered to achieve a safe and efficacious anti-chlamydial
vaccine.
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